SPNS3 and acute myeloid leukemia: To investigate the role of SPNS3 in AML, we divided 113 samples into the SPNS3-high (n = 57) and SPNS3-low group (n = 56) groups according to the levels of SPNS3 expression recorded in the TARGET database and used the edgeR package to analyze the intergroup difference in mRNA expression.